IHE participates at the ISPOR (International Society for Pharmaeconomics and Outcomes Research) European congress in Copenhagen 2-6 November.
Two posters within the area of diabetes will be presented by IHE staff:
Michael Willis will present the poster Risk Factor Clustering and the Economic Modeling of Type 2 Diabetes Mellitus (T2DM) and Sofie Persson will present The bias of ignoring cardioprotective effects in cost-effectiveness analysis in diabetes.
One cost effectiveness study in the area of cardiovascular disorders, co-authored by IHE:s Peter Lindgren, will also be presented Cost-effectiveness of evolocumab in atherosclerotic cardiovascular disease patients with varying risk profiles in Sweden.
If you want to meet with us in Copenhagen you can e-mail Managing Director Peter Lindgren, Senior Advisor Ulf Persson, Director Market Access Jonas Hjelmgren or Research Director Sofie Persson.